Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Tech Licenses PCR Patent From Utah Research Foundation

NEW YORK (GenomeWeb News) — Idaho Technology today said it has licensed PCR-amplification technology from Utah Research Foundation.
 
Idaho Tech said it has retained exclusive rights to the university’s Patent No. 7,160,998, entitled "Monitoring Amplification with FRET Probes,” which covers real-time PCR amplification kits using two DNA probes labeled with fluorescent molecules.
 
When these probes are hybridized to specific regions of DNA they create a fluorescent resonance energy transfer, or FRET, according to Idaho Tech.
 
Idaho Tech said it will use the technology in freeze-dried reagents that detect pathogens on its Ruggedized Advanced Pathogen Identification Device and Roche’s LightCycler instrument.
 
Financial terms of the license were not released.
 
On Jan. 5 Idaho Tech licensed PCR patents from Roche that it plans to use in its in vitro diagnostic products.
 
Six days later the company pocketed $3.5 million from Cephied as part of a settlement and a cross-licensing agreement that resolved a 2005 suit alleging that Cepheid infringed three PCR-related patents.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.